About: Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2001 (uk) article scientifique publié en 2001 (fr) im Mai 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2001 (ast) scientific article published on 01 May 2001 (en)
publication date	wds:Q73641695-5EB9CC75-3EA2-4E12-8678-E14FC2866565
publication date	2001-05-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73641695-00B1576F-EE73-461C-9B78-BAB5AE0BE2E3 wds:Q73641695-1DC45015-A3D6-4426-A917-1BDB087D160A wds:Q73641695-4C5686D2-B634-43CE-82AB-C062D5DA1203 wds:Q73641695-586C732D-F11F-414A-9D71-4F368159B2F6 wds:Q73641695-59AE4EAC-DAA7-4EFC-B9CE-98C0CC13B5DC wds:Q73641695-6503E87B-AABB-4A01-BC25-E3F3BBAF0106 wds:Q73641695-7EE3B597-2D3D-4727-9F4A-5ABA58970A6C wds:Q73641695-8B1862AA-03CD-4DEA-8BA6-70B9393DE466 wds:Q73641695-944003C0-E4D5-4DDF-854C-8AD2D431CBF1 wds:Q73641695-9BB84E67-2A02-40C0-B90A-1FDA1E481C51 wds:Q73641695-A26B7C00-4D42-4F44-8FA7-6031FFC56C6C wds:Q73641695-D7832241-4966-42BE-AB9F-1DEB3B1D0F55 wds:Q73641695-F1CBE71F-0B0C-4337-AC52-32D728750B8A
cites work	A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy Targeted therapy using alpha emitters Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity Synthesis, purification, and in vitro stability of 211At- and 125I-labeled amidobisphosphonates The preparation of astatine labelled proteins Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets Polonium metabolism in adult female baboons Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters Cytotoxicity of alpha-particle-emitting 5-[211At]astato-2'-deoxyuridine in human cancer cells.
author name string	wds:Q73641695-62EFCC4A-5D51-4FF3-AEDD-3DDBCAFF584C wds:Q73641695-7B38FC2A-A3FC-4C97-B92C-BDD23F9D3C6C wds:Q73641695-88B4E40B-48B0-46C6-B348-6122ACFCE3FF wds:Q73641695-B2F07272-B106-400C-AB98-1BD57B0C9DE0
author name string	E Olsen R H Larsen G Henriksen S Messelt
rdfs:label	Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (en) Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (nl)
skos:prefLabel	Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (en) Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (nl)
name	Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (en) Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (nl)
title	wds:Q73641695-4FD15B67-E7F8-43AB-B4AD-BBBE5833257F
title	Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At (en)
page(s)	wds:Q73641695-CF948437-E736-4975-8AE6-E93B6926EFA4
page(s)	839-844
instance of	wds:Q73641695-EF6FE983-702A-40BB-8685-D53BDCB8268C
instance of	scholarly article
PubMed ID	wds:Q73641695-D38DCDCB-4218-49DA-8A03-0250E3C5B535
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11258534
PubMed ID	11258534
published in	wds:Q73641695-D2EF011B-5822-42F6-BB5D-0C7F86C00390
published in	Applied Radiation and Isotopes
issue	wds:Q73641695-B62BF9F9-B993-4C1B-AB6C-612FFE76CEC3
volume	wds:Q73641695-AB436C3F-5D56-4A95-BA00-F9808918DF87
issue	5
volume	54
DOI	wds:Q73641695-57335B1B-F536-421D-811B-76A20C708FA0
DOI	http://dx.doi.org/10.1016/S0969-8043(00)00346-8
DOI	10.1016/S0969-8043(00)00346-8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73641695
is cites work of	Astatine Radiopharmaceuticals: Prospects and Problems Astatine-211: production and availability Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine
is cites work of	wds:Q27015038-C033436C-B958-44AB-9DBC-AAC30D6531C8 wds:Q57107703-2ED5782D-46F0-4A0F-9A9F-DD6FADBD5DA5 wds:Q33640550-2B6A3BEC-FA64-49CC-8431-02A40D4077B0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software